Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/induction-of-programmed-cell-death-by-inhibition-of-akt-with-the-qxX9NYjNFG
References (34)
-
T. Hideshima, L. Catley, H. Yasui, K. Ishitsuka, N. Raje, C. Mitsiades, K. Podar, N. Munshi, D. Chauhan, P. Richardson, K. Anderson (2005)
Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells.Blood, 107 10
-
A. Jemal, Taylor Murray, A. Samuels, Asma Ghafoor, Elizabeth Ward, M. Thun (2003)
Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 53
-
A. Argiris, E. Cohen, T. Karrison, B. Esparaz, A. Mauer, R. Ansari, Stuart Wong, Yi Lu, M. Pins, J. Dancey, E. Vokes (2006)
A phase II trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancerCancer Biology & Therapy, 5
-
M. Knowling, M. Blackstein, R. Tozer, V. Bramwell, J. Dancey, N. Dore, S. Matthews, E. Eisenhauer (2006)
A phase II study of perifosine (D-21226) in patients with previously untreated metastatic or locally advanced soft tissue sarcoma: A National Cancer Institute of Canada Clinical Trials Group trialInvestigational New Drugs, 24
-
S. Kondapaka, Sheo Singh, G. Dasmahapatra, E. Sausville, K. Roy (2003)
Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation.Molecular cancer therapeutics, 2 11
-
U. Naumann, S. Kügler, H. Wolburg, W. Wick, G. Rascher, J. Schulz, E. Conseiller, M. Bähr, M. Weller (2001)
Chimeric tumor suppressor 1, a p53-derived chimeric tumor suppressor gene, kills p53 mutant and p53 wild-type glioma cells in synergy with irradiation and CD95 ligand.Cancer research, 61 15
-
David Alberts (1999)
Treatment of refractory and recurrent ovarian cancer.Seminars in oncology, 26 1 Suppl 1
-
B. Hennessy, Yiling Lu, E. Poradosu, Qianghua Yu, Shuangxing Yu, H. Hall, M. Carey, Murali Ravoori, A. González-Angulo, R. Birch, I. Henderson, V. Kundra, G. Mills (2007)
Pharmacodynamic Markers of Perifosine EfficacyClinical Cancer Research, 13
-
G. Ruiter, S. Zerp, H. Bartelink, W. Blitterswijk, M. Verheij (2003)
Anti-cancer alkyl-lysophospholipids inhibit the phosphatidylinositol 3-kinase–Akt/PKB survival pathwayAnti-Cancer Drugs, 14
-
D. Ernst, E. Eisenhauer, N. Wainman, Mary Davis, R. Lohmann, T. Baetz, K. Bélanger, M. Smylie (2005)
Phase II Study of Perifosine in Previously Untreated Patients with Metastatic MelanomaInvestigational New Drugs, 23
-
M. Fraser, T. Bai, B. Tsang (2008)
Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear functionInternational Journal of Cancer, 122
-
L. Ummersen, Binger Kim, J. Volkman, R. Marnocha, K. Tutsch, J. Kolesar, R. Arzoomanian, D. Alberti, G. Wilding (2004)
A Phase I Trial of Perifosine (NSC 639966) on a Loading Dose/Maintenance Dose Schedule in Patients with Advanced CancerClinical Cancer Research, 10
-
H. Bailey, M. Mahoney, D. Ettinger, W. Maples, P. Fracasso, A. Traynor, C. Erlichman, S. Okuno (2006)
Phase II study of daily oral perifosine in patients with advanced soft tissue sarcomaCancer, 107
-
U. Naumann, J. Wischhusen, S. Weit, J. Rieger, H. Wolburg, U. Massing, M. Weller (2004)
Alkylphosphocholine-induced glioma cell death is BCL-XL-sensitive, caspase-independent and characterized by massive cytoplasmic vacuole formationCell Death and Differentiation, 11
-
R. Marsh, C. Lima, C. Lima, D. Levy, Edith Mitchell, K. Rowland, Al Benson (2007)
A Phase II Trial of Perifosine in Locally Advanced, Unresectable, or Metastatic Pancreatic AdenocarcinomaAmerican Journal of Clinical Oncology, 30
-
M. Rahmani, E. Reese, Yun Dai, C. Bauer, S. Payne, P. Dent, S. Spiegel, S. Grant (2005)
Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species.Cancer research, 65 6
-
M. Leist, M. Jäättelä (2001)
Four deaths and a funeral: from caspases to alternative mechanismsNature Reviews Molecular Cell Biology, 2
-
D. Floryk, T. Thompson (2008)
Perifosine induces differentiation and cell death in prostate cancer cells.Cancer letters, 266 2
-
H. Momota, E. Nerio, E. Holland (2005)
Perifosine inhibits multiple signaling pathways in glial progenitors and cooperates with temozolomide to arrest cell proliferation in gliomas in vivo.Cancer research, 65 16
-
Mei-Ling Chen, Pei-Zhang Xu, Xiao-ding Peng, William Chen, G. Guzman, Ximing Yang, A. Cristofano, P. Pandolfi, N. Hay (2006)
The deficiency of Akt1 is sufficient to suppress tumor development in Pten+/- mice.Genes & development, 20 12
-
S. Vink, J. Schellens, J. Beijnen, H. Sindermann, J. Engel, R. Dubbelman, G. Moppi, M. Hillebrand, H. Bartelink, M. Verheij (2006)
Phase I and pharmacokinetic study of combined treatment with perifosine and radiation in patients with advanced solid tumours.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 80 2
-
J. Cheng, C. Lindsley, G. Cheng, Huan Yang, S. Nicosia (2005)
The Akt/PKB pathway: molecular target for cancer drug discoveryOncogene, 24
-
N. Leighl, S. Dent, M. Clemons, Theodore Vandenberg, R. Tozer, David Warr, R. Crump, D. Hedley, Gregory Pond, J. Dancey, M. Moore (2008)
A Phase 2 study of perifosine in advanced or metastatic breast cancerBreast Cancer Research and Treatment, 108
-
Megan Cully, H. You, A. Levine, T. Mak (2006)
Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesisNature Reviews Cancer, 6
-
D. Levine, F. Bogomolniy, C. Yee, A. Lash, R. Barakat, P. Borgen, J. Boyd (2005)
Frequent Mutation of the PIK3CA Gene in Ovarian and Breast CancersClinical Cancer Research, 11
-
Mitsutoshi Nakamura, Johannes Rieger, Michael Weller, Jin Kim, P. Kleihues, H. Ohgaki (2000)
APO2L/TRAIL expression in human brain tumorsActa Neuropathologica, 99
-
Linda Bröker, F. Kruyt, G. Giaccone (2005)
Cell Death Independent of Caspases: A ReviewClinical Cancer Research, 11
-
M. Weller, J. Rieger, C. Grimmel, Erwin Meir, N. Tribolet, S. Krajewski, John Reed, A. Deimling, J. Dichgans (1998)
Predicting chemoresistance in human malignant glioma cells: The role of molecular genetic analysesInternational Journal of Cancer, 79
-
M. Crul, H. Rosing, G. Klerk, R. Dubbelman, M. Traiser, S. Reichert, N. Knebel, J. Schellens, J. Schellens, J. Beijnen, W. Huinink (2002)
Phase I and pharmacological study of daily oral administration of perifosine (D-21266) in patients with advanced solid tumours.European journal of cancer, 38 12
-
Mcguire Wp, Ozols Rf (1998)
Chemotherapy of advanced ovarian cancer.Seminars in Oncology, 25
-
Heath Elrod, Yidan Lin, P. Yue, Xuerong Wang, S. Lonial, F. Khuri, Shi-Yong Sun (2007)
The alkylphospholipid perifosine induces apoptosis of human lung cancer cells requiring inhibition of Akt and activation of the extrinsic apoptotic pathwayMolecular Cancer Therapeutics, 6
-
J. Engel, A. Honig, Tanja Schönhals, C. Weidler, S. Häusler, M. Krockenberger, T. Grunewald, Y. Dombrowski, L. Rieger, J. Dietl, J. Wischhusen (2008)
Perifosine inhibits growth of human experimental endometrial cancers by blockade of AKT phosphorylation.European journal of obstetrics, gynecology, and reproductive biology, 141 1
-
E. Posadas, J. Gulley, P. Arlen, A. Trout, H. Parnes, J. Wright, Min-Jung Lee, E. Chung, J. Trepel, A. Sparreboom, Clara Chen, E. Jones, S. Steinberg, A. Daniels, William II, W. Dahut (2005)
A phase II study of perifosine in androgen independent prostate cancerCancer Biology & Therapy, 4
-
D. Altomare, H. Wang, Kristine Skele, A. Rienzo, Andres Klein-Szanto, A. Godwin, J. Testa (2004)
AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growthOncogene, 23
- Publisher
- Springer Journals
- Copyright
- Copyright © 2010 by Springer-Verlag
- Subject
- Medicine & Public Health; Human Genetics ; Endocrinology; Obstetrics/Perinatology; Gynecology
- ISSN
- 0932-0067
- eISSN
- 1432-0711
- DOI
- 10.1007/s00404-010-1457-6
- pmid
- 20405296
- Publisher site
- See Article on Publisher Site
Abstract
Perifosine showed substantial cytotoxic effects in various in vitro models of ovarian cancer. Since anti-tumor effects were not confined to platinum-sensitive cells perifosine seems to be a good candidate for clinical studies in patients especially with platinum resistant ovarian cancer.
Journal
Archives of Gynecology and Obstetrics – Springer Journals
Published: Apr 20, 2010